Medpace Holdings (MEDP) Other Non-Current Assets (2015 - 2026)
Medpace Holdings' (MEDP) quarterly Other Non-Current Assets came in at $25.2 million in Q2 2026, up 5.86% YoY from $23.8 million in Q2 2025, and down 11.02% on a QoQ basis from $28.3 million in Q1 2026.
Medpace Holdings (MEDP) Other Non-Current Assets (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has 12 years of Other Non-Current Assets data on file, last reported at $25.2 million in Q2 2026.
- Quarterly Other Non-Current Assets rose 5.86% year-over-year to $25.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $25.2 million (up 5.86% YoY) and the FY2025 annual result came in at $21.9 million, down 1.42% from the prior year.
- Other Non-Current Assets declined to $25.2 million in Q2 2026, from $28.3 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $28.3 million in Q1 2026 to a low of $18.5 million in Q2 2024.
- A 5-year average of $22.2 million and a median of $22.0 million in 2023 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets soared 49.16% — and 2024, when it slipped 17.12%.
- Tracing MEDP's Other Non-Current Assets over 5 years: stood at $21.1 million in 2022, then advanced by 18.18% to $25.0 million in 2023, then retreated by 10.88% to $22.3 million in 2024, then declined by 1.42% to $21.9 million in 2025, then gained by 14.85% to $25.2 million in 2026.
- The last three Other Non-Current Assets figures came in at $25.2 million (Q2 2026), $28.3 million (Q1 2026), and $21.9 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 5.62 Bn |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | 4.39 Bn |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 567.73 Mn |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 1.18 Bn |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | 558.00 Mn |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | 51.00 Mn |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | 576.00 Mn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | 448.88 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 277.00 Mn |
| 10 | Medpace Holdings | 16.56 Bn | 16.06 Bn | 201.64 Mn | 25.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.20 Mn |
| Mar 31, 2026 | 28.32 Mn |
| Dec 31, 2025 | 21.94 Mn |
| Sep 30, 2025 | 25.72 Mn |
| Jun 30, 2025 | 23.80 Mn |
| Mar 31, 2025 | 21.52 Mn |
| Dec 31, 2024 | 22.25 Mn |
| Sep 30, 2024 | 23.06 Mn |
| Jun 30, 2024 | 18.45 Mn |
| Mar 31, 2024 | 20.41 Mn |
| Dec 31, 2023 | 24.97 Mn |
| Sep 30, 2023 | 20.83 Mn |
| Jun 30, 2023 | 22.26 Mn |
| Mar 31, 2023 | 22.03 Mn |
| Dec 31, 2022 | 21.13 Mn |
| Sep 30, 2022 | 18.63 Mn |
| Jun 30, 2022 | 19.12 Mn |
| Mar 31, 2022 | 19.48 Mn |
| Dec 31, 2021 | 17.42 Mn |
| Sep 30, 2021 | 16.49 Mn |